CompletedPhase 2NCT00508040
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
Studying Birdshot chorioretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Christine FARDEAU, MDAssistance Publique Hopitaux de Paris
- Intervention
- interferon alpha 2a(drug)
- Enrollment
- 58 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2013
Study locations (1)
- Hopital La Pitie Salpetriere, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00508040 on ClinicalTrials.govOther trials for Birdshot chorioretinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06587828A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseTScan Therapeutics, Inc.
- RECRUITINGNCT05153057Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD)Assistance Publique - Hôpitaux de Paris